Target intelligence / Profile preview

ENAH pseudogene 1 (ENAHP1)

Target
ENAHP1
Molecular classification
Other (Pseudogene, non-coding RNA)
01

Overview

ENAH pseudogene 1 (ENAHP1) is a **pseudogene**, which means it is a non-functional genomic sequence resembling the functional ENAH (enabled homolog) gene. Pseudogenes like ENAHP1 arise from gene duplication or retrotransposition events that result in loss of protein-coding ability due to mutations. While some pseudogenes can function through regulatory RNA activity, the specific biological or clinical roles of ENAHP1 have not been described in the scientific literature[2][3]. Unlike its functional parental gene, ENAH, which encodes an actin cytoskeleton regulator protein, ENAHP1 does not produce a protein and is not implicated as a therapeutic target, biomarker, or disease gene. If you need structured data: - ENAH pseudogene 1 does not fit the usual profile of a "target molecule/receptor". - There is currently no evidence supporting a therapeutic, biomarker, or regulatory role for ENAHP1. If you seek information about the functional ENAH gene/protein (Enabled homolog), clarification would be needed, as the pseudogene itself (ENAHP1) is non-functional.

Other names
ENAH, actin regulator pseudogeneenabled homolog pseudogeneENAHP1
02

Biological functions

None established; pseudogenes are typically non-functional, but some have regulatory RNA roles in gene expression[2]. No specific functions described for ENAHP1.
03

Disease associations

None established. Some pseudogenes have been associated with cancer biology or epigenetic regulation, but no data for ENAHP1[2][3].

Beyond the preview

Go deeper on ENAH pseudogene 1 (ENAHP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ENAH pseudogene 1 (ENAHP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call